USPTO serial 79164979
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $850
Zakrytoe aktsionernoe obshchestvo "Evalar"
RU-659332 Altai Territory, RU
Other trademarks owned by Zakrytoe aktsionernoe obshchestvo "Evalar"
Zakrytoe aktsionernoe obshchestvo "Evalar"
RU-659332 Altai Territory, RU
Other trademarks owned by Zakrytoe aktsionernoe obshchestvo "Evalar"
Zakrytoe aktsionernoe obshchestvo "Evalar"
RU-659332 Altai Territory, RU
Other trademarks owned by Zakrytoe aktsionernoe obshchestvo "Evalar"
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elise Tenen-Aoki
Elise Tenen-Aoki TA IP Law, P.C. A Law Corporation14271 Jeffrey Road, Suite 313Irvine, CA 92620UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Greases for cosmetic purposes; cosmetic creams; hair lotions; lotions for cosmetic purposes; beauty masks; oils for cosmetic purposes; essential oils; cleansing milk for toilet purposes; cosmetic preparations for baths; non-medicated mouthwash; cosmetic preparations for slimming purposes; sunscreen preparations; potpourri; cosmetic sun-tanning preparations; cosmetic preparations for skin care; cosmetics; shampoos; extracts of flowers sold as components of cosmetics; ethereal essences and extracts of herbs for cosmetic purposes ] | SECTION 71 - CANCELLED | — |
| 005 | [ Analgesics; antibiotics; balms for medical purposes; dietary fiber for use as an ingredient in the manufacture of dietary supplements; ] mineral food supplements; nutritional supplements; [ medicinal roots; collodion for pharmaceutical purposes; licorice for pharmaceutical purposes; candy for medical purposes; medicines for alleviating constipation; liniments; antibiotic ointments; medicinal oils for the treatment of skin diseases, for use as medicated skin care preparations, as medicated hair care preparations; drugs for medical purposes, namely, antimicrobial preparations for inhibiting microbiological decomposition in food, beverages and pharmaceuticals; medicines for human purposes, namely, pharmaceutical preparations for treating of disorders of gastrointestinal system; medicinal drinks; flour for pharmaceutical purposes; mint for pharmaceutical purposes; medicinal infusions for treating of disorders of the nervous, immune, cardiovascular and metabolic systems, the gastro-intestinal system, the respiratory and genito-urinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology, ophthalmology; decoctions for pharmaceutical purposes for treating of disorders of the nervous, immune, cardio-vascular and metabolic systems, the gastro-intestinal system, the respiratory and genito-urinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology, ophthalmology; food for babies; ] vitamin preparations; [ hemorrhoid treatment preparations; eye-washes; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; medicinal hair growth preparations; ] preparations of trace elements for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardlo-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genito-urinary system, the gastro-intestinal system, for use as dietetic supplements, nutritional additives for medical purposes; [ pharmaceutical preparations for the treatment of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the rnusculo-skeletal system, the genito-urinary system, the gastro-intestinal system, for the treatment of inflammatory disorders, for use in dermatology; enzyme preparations for medical purposes for the treatment of disorders of gastro-intestinal system; chemico-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the vascular and metabolic systems, the respiratory and genito-urinary systems, musculoskeletal and inflammatory disorders or for use in dermatology, ophthalmology, for gastro-enterology, for the prevention and treatment of ocular disorders, for use as anti-infective, antiparasitic, antibiotic, anti-bacterial, antiviral and antifungal; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of disorders of the nervous system, the immune system, the vascular and metabolic systems, the respiratory and genito-urinary systems, musculoskeletal and inflammatory disorders or for use in dermatology, ophthalmology, for gastro-enterology, for the prevention and treatment of ocular disorders, for use as anti-infective, antiparasitic, antibiotic, anti-bacterial, antiviral and antifungal; collyrium; dietetic foods, namely, crackers adapted for medical use; by-products of the processing of cereals for medical purposes; propolis for medicinal or therapeutic purposes; asthmatic tea; ] linseed dietary supplements [ ; syrups for pharmaceutical purposes for the treatment of cough; soporifics; bath salts for medical purposes; malt for pharmaceutical purposes; medicinal alcohol; appetite suppressants for medical purposes; medical preparations for slimming purposes; mouthwashes for medical purposes; febrifuges; purgatives; antiparasitic preparations; sedatives; tranquilizers; laxatives; digestives for pharmaceutical purposes; appetite suppressant pills; slimming pills; medicinal herbs; charcoal for pharmaceutical purposes; enzymes for medical purposes; medicinal tea; herbal teas for medicinal purposes; plant and herb extracts for medicinal purposes; elixirs, namely, pharmaceutical preparations for the treating of disorders of the nervous, immune, cardio-vascular and metabolic systems, the gastro-intestinal system, the respiratory and genito-urinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology ] | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 19, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 31, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 7, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 7, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 11, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 11, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 11, 2022 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 9, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 12, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 14, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 14, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 14, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 14, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 14, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 14, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 21, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2016 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 25, 2016 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 24, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 8, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 17, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 17, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 17, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 2, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 1, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2016 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 30, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2016 | PAPER RECEIVED | — | |
| Dec 3, 2015 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 10, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 28, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 26, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2015 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 5, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 10, 2015 | PAPER RECEIVED | — | |
| Jun 7, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 21, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 21, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 20, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 16, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 14, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |